Seres Health Receives $10,000,000 Series B Funding Round

  • Feed Type
  • Date
    6/9/2014
  • Company Name
    Seres Health
  • Mailing Address
    161 First Street Cambridge, MA 02142 USA
  • Company Description
    Seres Health is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic therapeutic products to treat important diseases by targeting the underlying biology of the human microbiome.
  • Website
    http://www.sereshealth.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $10,000,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Seres will use the Series B proceeds to advance its rapidly growing pipeline of Ecobiotic therapeutics including its lead candidate, SER-109, which is currently in clinical testing for the treatment of recurrent C. difficile.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor